Disease / condition

Diabetes Mellitus, Type 1 clinical trials

Free access to 510 studies·10+ countries·Updated daily68 recruiting
510
Total trials
10+
Countries
10+
Sponsors
68
Recruiting
By phase
N/A279
Phase 272
Phase 353
Phase 147
Phase 436
By status
Completed325
Recruiting68
Not yet recruit...42
Unknown28
Terminated17
Top countries
United States of America153
Germany24
Canada24
Italy16
United Kingdom15
Top sponsors
Eli Lilly and Comp...40
Novo Nordisk A/S27
University of Virg...19
Sanofi17
National Institute...10
Recent trials
Latest clinical trials for Diabetes Mellitus, Type 1
2014-004639-38
Apidra Children & Adolescents Study
Sanofi
NCT06418464Not yet recr...
Efficacy and Safety of an Artificial-pancreas-like Learning-based Control in Type 1 Diabetes on Multiple Daily Injection Therapy
Peking University People's Hos...
NCT06414824Recruiting
The isCGM Use and Hypoglycemic Episodes and Fear of Hypoglycemia in Newly Diagnosed Type 1 Diabetes
Jagiellonian UniversityPoland
NCT06408311·Phase 1Recruiting
Safety of ENC-201-CED ENCRT
EncellinCanada
NCT06334484Not yet recr...
Effect of Advanced Hybrid Closed Loop System on Adjunctive Continuous Glucose Monitoring Metrics
Fondazione Policlinico Univers...Italy
NCT06326489·Phase 4Recruiting
Evaluating the Efficacy and Quality of Life Impact of Transitioning to Advanced Hybrid Closed-Loop Insulin Pump Therapy in Romanian Children With Type 1 Diabetes Mellitus
ELIAS Emergency University Hos...Romania
NCT06325111Recruiting
Determinants of Glycaemic Control in Children With Type 1 Diabetes
IRCCS Burlo GarofoloItaly
NCT06334133·Phase 3Not yet recr...
Cadisegliatin as Adjunctive Therapy in Type 1 Diabetes
vTv Therapeutics
NCT06317454Recruiting
Determinants of Metabolic Control in Children With Type 1 Diabetes Mellitus
IRCCS Burlo GarofoloItaly
NCT06325202Not yet recr...
Closed Loop and Education for Hypoglycemia Awareness Restoration
Milton S. Hershey Medical Cent...Australia,United Kingdom,United States of America
NCT06305377Not yet recr...
Achieving Rapid, Safe and Sustained Glucose Control in Adolescents With Suboptimally Controlled Type 1 Diabetes Using Advanced Hybrid Closed Loop Systems
Giulio Frontino
NCT06310980Not yet recr...
Pilot Study to Verify Effect of Smartpen Coordinated With Glucose Sensor.
Giulio Frontino
NCT06264271Completed
The Effect of Nutrition Education on Glycemic Control in Patients With Type 1 Diabetes
Charles University, Czech Repu...Czech
NCT06238778·Phase 2Recruiting
Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec
Diasome Pharmaceuticlas, Inc.United States of America
NCT06282055Not yet recr...
Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes
DCB Research AG
NCT06229236Recruiting
Assessing Effectiveness of a Diabetes Navigator in Increasing Progression of Advanced Diabetes Technologies
Johns Hopkins UniversityUnited States of America
NCT06230276Recruiting
Managing of Missed Meal Bolus by HCL Systems
Zdeněk ŠumníkCzech
NCT06236256Recruiting
Advanced Hybrid Closed Loop System (AHCL) in Older Patients With Type 1 Diabetes Mellitus
Sheba Medical CenterIsrael
NCT06154135Enrolling by...
Insulin Delivery Using the DBLG1 Closed-loop on Glycemic Control and PROMs in Adults Living With Type 1 Diabetes
Erasme University HospitalBelgium
NCT06080542Completed
Influence of Aerobic Exercise and HIIT on Glycemic Control in Adult Men With Type 1 Diabetes (TAILOR/1b)
University of ValenciaSpain
About this record

Access comprehensive clinical trial information for Diabetes Mellitus, Type 1 through Pure Global AI's free database. This collection includes 510 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 68 trials are actively recruiting participants.

Research for Diabetes Mellitus, Type 1 is being conducted in United States of America, Germany, Canada and 7+ other countries. Leading sponsors include Eli Lilly and Company and Novo Nordisk A/S. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 510 clinical trials studying Diabetes Mellitus, Type 1, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Eli Lilly and Company, Novo Nordisk A/S, University of Virginia, among others.